Infectious Diseases 1101 - Infectious Disease Alert - Jan 01, 2007

Target Audience:

This activity is intended for the infectious disease specialist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Stan Deresinski, MD, FACP
Clinical Professor of Medicine
Stanford
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Peer Reviewer
Connie Price, MD
Assistant Professor
University of Colorado School of Medicine

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center
Section Editor
Updates
Section Editor
HIV

Associate Editors
Hal B. Jenson, MD, FAAP
Chair, Department of Pediatrics
Director, Center for Pediatric Research
Eastern Virginia Medical School and Children's Hospital of the King's Daughter
Tufts University School of Medicine
Chief Academic Officer, Baystate Medical Center
Springfield, MA

Robert Muder, MD
Hospital Epidemiologist
Pittsburgh VA Medical Center
Section Editor
Hospital Epidemiology

Dean L. Winslow, MD, FACP
Chief, Division of AIDS Medicine
Santa Clara Valley Medical Center
Clinical Professor of Medicine
Stanford University School of Medicine
Section Editor, HIV

Authors
Lin H. Chen, MD
Assistant Clinical Professor
Harvard Medical School
Director, Travel Resource Center
Mount Auburn Hospital
Cambridge, MA

Mary-Louise Scully, MD
Sansum-Santa Barbara Medical Foundation Clinic
Santa Barbara, CA

Melinda G. Young

Subjects:

  • Listeria Meningitis
  • Human Papillomavirus Vaccine: For Boys, Too?
  • Panton-Valentine Leukocidin
  • TMC125 (Etravirine), a Second Generation Non-Nucleoside Reverse Transcriptase Inhibitor
  • Multidrug-Resistant Tuberculosis (MDR-TB)
  • Treatment of Cholera in Adults with Single-Dose Azithromycin
  • New Once-a-Day Pill Submitted to FDA
  • Updates

Objectives:

  • To discuss the diagnosis and treatment of infectious diseases
  • To present current data regarding use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • To present the latest information regarding the pros, cons, and cost-effectiveness of new and traditional diagnostic tests
  • To discuss new information regarding how infectious diseases (eg, AIDS) are transmitted and how such information can lead to the development of new therapy

Financial Disclosure:

Infectious Disease Alert’s Physician Editor, Stan Deresinski, MD, FACP, serves on the speaker’s bureau of Merck, Pharmacia, GlaxoSmithKline, Pfizer, Bayer, and Wyeth, and does research for Merck.

Peer Reviewer, Connie Price, MD, Updates Author, Carol A. Kemper, MD, FACP, and Authors , Lin H. Chen, MD, Mary-Louise Suclly, MD, and Medlinda G. Young, reports no financial relationships relevant to this field of study.

Associate Editor, Dean L. Winslow, MD, FACP, is a consultant for Bayer Diagnostics, and on the speaker’s bureau for GlaxoSmithKline and Pfizer.

Associate Editor, Hal Jenson, MD, is on the speaker's bureau for Merck.

Associate Editor, Robert Muder, MD, does research for Aventis and Pharmacia.

Copyright 2007 AHC Media. All rights reserved.